Transwell assay showing increased invasion in SNB19 and U251 glioma cells transfected with FAM111B-overexpressing lentivirus, compared to controls. Magnification ×20 Study shows FAM111B overexpression ...

A Ludwig Cancer Research study has discovered that the metabolic decline that accompanies aging impairs the efficacy of CAR-T ...

Age-related decline in the immune system can have a measurable impact on CAR-T cell therapy — one of the most advanced forms ...

A Ludwig Cancer Research study has discovered that the metabolic decline that accompanies aging impairs the efficacy of CAR-T cell therapy, an immunotherapy in which T cells of the immune system are ...

Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure. Chimeric antigen receptor (CAR) T cell therapy is one of the most promising cancer treatments.

In a breakthrough finding, researchers have revealed that age-related immune decline can significantly impair the ...

Age-related decline in the immune system can have a measurable impact on CAR-T cell therapy -- one of the most advanced form ...

The team used NAD-boosting compounds currently under clinical investigation for other conditions, demonstrating that this ...

As people age, their immune systems become less efficient, posing a challenge for cancer therapies that rely on harnessing immune cells.

A study by Swiss researchers highlights the challenges aging poses for CAR-T cell therapy, a groundbreaking cancer treatment.

Mice roaming your home is never a good thing. As adorable as their twitchy noses and big ears may be, these little freeloaders are known to nibble on cords, snack on your pantry stash and leave ...